Engineering Medicines To Improve Patient Care Arlene Morris Chief Executive Officer, Willow Advisors Arlene Morris currently serves as Chief Executive Officer at Willow Advisors, LLC, a consultancy advising biotech companies on financing, strategy and business development. Previously, she served as the President, Chief Executive Officer and a member of the board of directors of Syndax Pharmaceuticals, Inc, a privately held biotechnology company, and Affymax, Inc., a publicly traded biotechnology company. Ms. Morris has also held executive positions at Clearview Projects, Inc., Coulter Pharmaceutical, Inc., Scios Inc., Johnson & Johnson and board of director roles at Biodel Inc., and Dimension Therapeutics, Inc. Arlene is currently a member of the board of directors of Viveve, Inc., Palatin Technologies, Inc., and Cogent Biosciences, Inc., and director emeritus for the Foundation for Research and Development at the Medical University of South Carolina where she served as Chair. She also serves as a trustee of Carlow University where she received a B.A. in Biology and Chemistry.